News / USA

Researcher Blueprints Ovarian Cancer Tumors

Laura Shawver fights to change one-size-fits-all approach to treatment

Clearity Foundation founder Laura Shawver finishes a charity run for molecular profiling of ovarian cancer patients.
Clearity Foundation founder Laura Shawver finishes a charity run for molecular profiling of ovarian cancer patients.

Multimedia

Audio
Rosanne Skirble

Ovarian cancer is called a “silent killer” because by the time symptoms appear and diagnosis is made, it is generally too late for a cure.



Last year, 22,000 women were diagnosed with the disease in the United States; 14,000 of them died.

Laura Shawver, a scientist cancer researcher and commercial drug developer, is fighting back by offering ovarian cancer patients a molecular profile or blueprint of their tumor.  

Shawver, a cancer survivor who has been in remission since 2006, had the same initial treatment as every ovarian cancer patient.

“The the same treatment that’s been around for at least 30 years," she says. "We all get surgery and we all get chemotherapy. Most people have a response, and we think we’re cured.”

Shawver is one of the few lucky ones. Ovarian cancer returns in 75 percent of  patients.

“When we recur that’s when the guesswork comes in.” Shawver says that’s because ovarian tumors differ so widely from each other and respond differently to drugs. So, women end up going through round after round of different chemotherapy drugs. “It’s a random selection and, unfortunately, that means that the patient frequently gets toxicity without benefit.”  

That has been Sheila Connor’s experience. She was diagnosed with late-stage ovarian cancer in 2007. After initial surgery and chemotherapy, the cancer returned four times over four years.

“The longest remission I had was about eight months,” says Connor.

Sheila Connor, who has lived with ovarian cancer since 2007, has opted to leave treatment.
Sheila Connor, who has lived with ovarian cancer since 2007, has opted to leave treatment.

She tried a battery of drugs. One would work for a time. Another would complicate her illness. “All the skin on my hands and feet peeled off, and I had mouth sores from it that I had to be hospitalized because I couldn’t eat. I couldn’t eat anything without pain medicine.”

Connor recently left a clinical trial because her cancer had progressed. She's decided to stop treatment.

Shawver believes the one-size-fits-all treatment approach doesn’t work. “There’s probably a better choice when they recur - and the chemo agents that are available, the molecular targeted agents that are available, the clinical trials that are available - should all be taken into consideration when faced with recurrent disease.”

In 2007, Shawver started the Clearity Foundation. The nonprofit offers ovarian cancer patients a molecular profile, or blueprint, of their tumor. That helps target drug therapy to a specific tumor.

Profiles are available for other cancers, but this is the first time it’s being applied to ovarian cancer.

Clearity compares the diseased ovarian tumor to others in its database. That suggests which of the dozen or so drugs regularly used for ovarian cancer might be most effective, based on their success in similar cases.

The foundation also screens for biological markers, which can indicate how a tumor will respond to certain chemotherapy agents. This opens options to try other cancer-fighting drugs.

That profiling wasn’t available when Sheila Connor's cancer first recurred. She says it’s a tool that can help patients make informed decisions. “If you had some idea, whether you would respond to these drugs you could try something else, try another standard drug and then if the other standard drugs don’t work, then I know that I need to get on a clinical trial.”

That is how Shawver is determined to change the way ovarian cancer is treated: one patient at a time. “In order to for the paradigm to really shift, we need for every woman who has recurring ovarian cancer to be willing to get her tumor profiled, to be willing to get on the right clinical trial and to really educate themselves about what are the treatment options.”

Shawver says this approach not only improves the quality of life for women with recurring ovarian cancer, it can also lead to the development of specific new drugs for the often deadly disease.

You May Like

Mali's Female Basketball Players Rebound After Islamist Occupation

Islamist extremists ruled northern Mali for most of 2012, imposing strict Sharia law, and now some 18 months later, the region is slowly getting back on its feet More

Video Vietnamese Staging Chinese Product Boycott After Oil Rig Spat

Many Chinese-made products go unsold, for now, with numerous Vietnamese consumers still angry over recent dispute More

Koreas Mark 61st Anniversary of War Armistice

Muted observances on both sides of heavily-armed Demilitarized Zone that separates two decades-long enemies More

This forum has been closed.
Comments
     
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Students in Business for Themselvesi
X
Mike O'Sullivan
July 26, 2014 11:04 AM
They're only high school students, but they are making accessories for shoes, fabricating backpacks and doing product photography - all through their own businesses. It's the result of a partnership between a non-profit organization that teaches entrepreneurship and their schools. VOA's Mike O'Sullivan and Deyane Moses met the budding entrepreneurs near Los Angeles.
Video

Video Students in Business for Themselves

They're only high school students, but they are making accessories for shoes, fabricating backpacks and doing product photography - all through their own businesses. It's the result of a partnership between a non-profit organization that teaches entrepreneurship and their schools. VOA's Mike O'Sullivan and Deyane Moses met the budding entrepreneurs near Los Angeles.
Video

Video Astronauts Train in Underwater Lab

In the world’s only underwater laboratory, four U.S. astronauts train for a planned visit to an asteroid. The lab - called Aquarius- is located five kilometers off Key Largo, in southern Florida. Living in close quarters and making excursions only into the surrounding ocean, they try to simulate the daily routine of a crew that will someday travel to collect samples of a rock orbiting far away from earth. VOA’s George Putic has more.
Video

Video Not Even Monks Spared From Thailand’s Junta-Backed Morality Push

With Thailand’s military government firmly in control after May’s bloodless coup, authorities are carrying out plans they say are aimed at restoring discipline, morality and patriotism to all Thais. The measures include a crackdown on illegal gambling, education reforms to promote students’ moral development, and a new 24-hour phone hotline for citizens to report misbehaving monks. Steve Sandford reports from Bangkok.
Video

Video Virtual Program Teaches Farming Skills

In a fast-changing world beset by unpredictable climate conditions, farmers cannot afford to ignore new technology. Researchers in Australia are developing an online virtual world program to share information about climate change and more sustainable farming techniques for sugar cane growers. As VOA's Zlatica Hoke reports, the idea is to create a wider support network for farmers.
Video

Video Airline Expert: Missile will Show Signature on Debris

The debris field from Malaysia Airlines Flight 17 is spread over a 21-kilometer radius in eastern Ukraine. It is expected to take investigators months to sort through the airplane pieces to learn about the missile that brought down the jetliner and who fired it. VOAs Carolyn Presutti explains how this work will be done.
Video

Video Treatment for Childhood Epilepsy Heats up Medical Marijuana Debate

In the United States, marijuana is classed as an illegal drug by the federal government. But nearly half the states have legalized it, to some degree. Proponents say some strains of marijuana might have exceptional health benefits, for treating pain or inflammation in chronic conditions such as cancer, multiple sclerosis and epilepsy. Shelley Schlender reports on a strain of medical marijuana developed in Colorado that is reputed to reduce seizures in childhood epilepsy
Video

Video Airbus Adds Metal 3D Printed Parts to New Jets

By the end of this year, European aircraft manufacturing consortium Airbus plans to deliver the first of its new, extra-wide-body passenger jets, the A350-XWB. Among other technological innovations, the new plane will also incorporate metal parts made in a 3-D printer. VOA's George Putic has more.
Video

Video AIDS Conference Welcomes Exciting Developments in HIV Treatment, Prevention

Significant strides have been made in recent years toward the treatment and prevention of HIV, the virus that causes AIDS. This year, at the International AIDS Conference, the AIDS community welcomed progress on a new pill that may prevent transmission of the deadly virus. VOA’s Anita Powell reports from Melbourne, Australia.
Video

Video IAEA: Iran Turns its Enriched Uranium Into Less Harmful Form

Iran has converted its stockpiles of enriched uranium into a less dangerous form that is more difficult to use for nuclear weapons, according to the United Nations’ Atomic Energy Agency. The move complies with an interim deal reached with Western powers on Iran's nuclear program last year, in exchange for easing of sanctions. Henry Ridgwell reports for VOA from London.

AppleAndroid